United Kingdom Research and Innovation

IQVIA Joins UK Government Collaboration to Provide Single Research Platform to Speed Development of New COVID-19 Treatments

Retrieved on: 
Wednesday, April 29, 2020
Technology, Research, Infectious diseases, Clinical trials, Biotechnology, Other Health, Health, Data management, Science, Health, Articles, Contract research organizations, Life sciences, Clinical research, Pharmaceutical industry, IQVIA, National Institute for Health Research, Clinical pharmacology, Clinical trial, Medical research, United Kingdom Research and Innovation

IQVIA will provide a single research platform across the United Kingdom to facilitate multiple clinical trials regardless of sponsor.

Key Points: 
  • IQVIA will provide a single research platform across the United Kingdom to facilitate multiple clinical trials regardless of sponsor.
  • ACCORD-2 (ACcelerating COVID-19 Research & Development) brings together the National Institute for Health Research (NIHR), 10 of its Biomedical Research Centres led by Southampton Biomedical Research Centre, UK Research and Innovation (UKRI) and industry partners.
  • The ACCORD-2 initiative has received regulatory approval and will immediately begin enrollment of COVID-19 patients into trials to allow urgent access to potential treatments.
  • IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry.

BerGenBio's Bemcentinib Selected to Be Fast-tracked As Potential Treatment for COVID-19 Through New National UK Government Clinical Trial Initiative

Retrieved on: 
Tuesday, April 28, 2020
RTT, Oncology, United Kingdom Research and Innovation, Cancer, Metástasis

The ACcelerating COVID-19 Research & Development platform (ACCORD) study is being funded by the Department of Health and Social Care (DHSC) and UK Research and Innovation (UKRI).

Key Points: 
  • The ACcelerating COVID-19 Research & Development platform (ACCORD) study is being funded by the Department of Health and Social Care (DHSC) and UK Research and Innovation (UKRI).
  • If positive results are seen, bemcentinib will advance rapidly into the large-scale Phase III trials currently in progress across the UK.
  • Bemcentinib has previously demonstrated a key role in cancer treatment: preventing immune evasion, drug resistance and metastasis in a variety of cancer trials.
  • Cell Rep 2017 18:324
    BerGenBio will be hosting a live webcast and Q&A session at 10.00 CEST tomorrow, 29 April:

BerGenBio's Bemcentinib Selected to Be Fast-tracked As Potential Treatment for COVID-19 Through New National UK Government Clinical Trial Initiative

Retrieved on: 
Tuesday, April 28, 2020
RTT, Oncology, United Kingdom Research and Innovation, Cancer, Metástasis

The ACcelerating COVID-19 Research & Development platform (ACCORD) study is being funded by the Department of Health and Social Care (DHSC) and UK Research and Innovation (UKRI).

Key Points: 
  • The ACcelerating COVID-19 Research & Development platform (ACCORD) study is being funded by the Department of Health and Social Care (DHSC) and UK Research and Innovation (UKRI).
  • If positive results are seen, bemcentinib will advance rapidly into the large-scale Phase III trials currently in progress across the UK.
  • Bemcentinib has previously demonstrated a key role in cancer treatment: preventing immune evasion, drug resistance and metastasis in a variety of cancer trials.
  • Cell Rep 2017 18:324
    BerGenBio will be hosting a live webcast and Q&A session at 10.00 CEST tomorrow, 29 April:

FER0798596

Retrieved on: 
Saturday, July 6, 2019
Eir, United Kingdom Research and Innovation, Eir, Craigends, Telecommunications in Ireland, Economy

The complainant has requested information about Sneddon Law Community Windfarm and Craigends Borehole from the British Geological Survey, which is a component part of UK Research and Innovation (UKRI).  UKRI released some information and has withheld other information – Test Reports and correspondence – under regulation 12(5)(f) of the EIR (interests of person providing the information). The Commissioner’s decision is that the disputed information is excepted from disclosure under regulation 12(5)(f) of the EIR, and that the public interest favours maintaining the exception. The Commissioner does not require UKRI to take any remedial steps.

Key Points: 
  • The complainant has requested information about Sneddon Law Community Windfarm and Craigends Borehole from the British Geological Survey, which is a component part of UK Research and Innovation (UKRI).
  • UKRI released some information and has withheld other information Test Reports and correspondence under regulation 12(5)(f) of the EIR (interests of person providing the information).
  • The Commissioners decision is that the disputed information is excepted from disclosure under regulation 12(5)(f) of the EIR, and that the public interest favours maintaining the exception.
  • The Commissioner does not require UKRI to take any remedial steps.

Committee to question UKRI on research funding in universities

Retrieved on: 
Saturday, June 15, 2019
United Kingdom Research and Innovation, Brexit, European Union, Higher education in the United Kingdom, Europe

Lords Science and Technology Committee takes evidence on Tuesday 18 June at 10.25am

Key Points: 
  • Over two evidence sessions the House of Lords Science and Technology Committee questions witnesses including representatives from UK Research and Innovation (UKRI) and Lord Macpherson of Earl's Court as part of its ongoing inquiry into science research funding in universities.
  • The Committee will explore with UKRI and Lord Macpherson what difficulties universities might face if the Augar Review recommendations are implemented whilst also considering other issues such as why QR funding is falling and how Brexit might impact research funding from EU sources.
  • Tuesday 18 Junein Committee Room 4A, Palace of Westminster
    David Sweeney, Executive Chair of Research England, UKRI
    Lord Macpherson of Earl's Court, former Permanent Secretary to the Treasury
    Why has QR funding been falling as a proportion of Research Council funding?
  • To what extent is it expected that universities will have to obtain funding from elsewhere to make up the full economic cost of research, when QR funding is not enough?

Committee to question UKRI on research funding in universities

Retrieved on: 
Saturday, June 15, 2019
United Kingdom Research and Innovation, Brexit, European Union, Higher education in the United Kingdom, Europe

Lords Science and Technology Committee takes evidence on Tuesday 18 June at 10.25am

Key Points: 
  • Over two evidence sessions the House of Lords Science and Technology Committee questions witnesses including representatives from UK Research and Innovation (UKRI) and Lord Macpherson of Earl's Court as part of its ongoing inquiry into science research funding in universities.
  • The Committee will explore with UKRI and Lord Macpherson what difficulties universities might face if the Augar Review recommendations are implemented whilst also considering other issues such as why QR funding is falling and how Brexit might impact research funding from EU sources.
  • Tuesday 18 Junein Committee Room 4A, Palace of Westminster
    David Sweeney, Executive Chair of Research England, UKRI
    Lord Macpherson of Earl's Court, former Permanent Secretary to the Treasury
    Why has QR funding been falling as a proportion of Research Council funding?
  • To what extent is it expected that universities will have to obtain funding from elsewhere to make up the full economic cost of research, when QR funding is not enough?

B2M Solutions Secures Innovate UK Funding

Retrieved on: 
Monday, June 3, 2019
Innovation, Articles, Science and technology in the United Kingdom, Department for Business, Energy and Industrial Strategy, Innovate UK, Knowledge transfer, Technology strategy, Tim Sawyer, United Kingdom Research and Innovation, B2M

"Innovate UK is supporting B2M Solutions with an innovation loan for a project to use artificial intelligence in its software to meet the needs of its customers," says Tim Sawyer, Chief Investment Officer at Innovate UK.

Key Points: 
  • "Innovate UK is supporting B2M Solutions with an innovation loan for a project to use artificial intelligence in its software to meet the needs of its customers," says Tim Sawyer, Chief Investment Officer at Innovate UK.
  • B2M Solutions is a global software company dramatically improving how enterprise mobility is operated and managed.
  • Founded in 2002, B2M is a privately held company based in Abingdon, UK, with North American operations in Atlanta, Ga., U.S.A. For additional information, visit http://www.b2msolutions.com .
  • Innovate UK is part of UK Research and Innovation, a non-departmental public body funded by a grant-in-aid from the UK government.

Science Research Funding in Universities - Lords Committee launches new inquiry

Retrieved on: 
Tuesday, May 14, 2019
Countries, International organizations, Education, Brexit, Euroscepticism in the United Kingdom, Withdrawal from the European Union, Universities in the United Kingdom, United Kingdom Research and Innovation, University, Science, United Kingdom

Lords Science and Technology Committee to investigate Science Research Funding in Universities

Key Points: 
  • The House of Lords Science and Technology Select Committee launches a new inquiry to assess the impact of potential changes in funding on the ability of UK universities to conduct high-quality scientific research.
  • What proportion of England and Wales' overall science research is done in universities?
  • Has the establishment of UKRI affected the way in which universities apply for funding for research?
  • If Brexit led to a reduction in EU students studying in England and Wales, would that affect science research capabilities in universities?

Science Research Funding in Universities - Lords Committee launches new inquiry

Retrieved on: 
Tuesday, May 14, 2019
Countries, International organizations, Education, Brexit, Euroscepticism in the United Kingdom, Withdrawal from the European Union, Universities in the United Kingdom, United Kingdom Research and Innovation, University, Science, United Kingdom

Lords Science and Technology Committee to investigate Science Research Funding in Universities

Key Points: 
  • The House of Lords Science and Technology Select Committee launches a new inquiry to assess the impact of potential changes in funding on the ability of UK universities to conduct high-quality scientific research.
  • What proportion of England and Wales' overall science research is done in universities?
  • Has the establishment of UKRI affected the way in which universities apply for funding for research?
  • If Brexit led to a reduction in EU students studying in England and Wales, would that affect science research capabilities in universities?

Balance and effectiveness of research and innovation spending examined

Retrieved on: 
Tuesday, November 20, 2018
Research, Economy, Science, University of Sussex, Research councils, Science Policy Research Unit, United Kingdom Research and Innovation, Science policy, Fraunhofer Society, Economic and Social Research Council

Science and Technology Committee explore issues including international comparisons of R&D spending and the regional distribution of investment

Key Points: 
  • The Science and Technology Committeeexplores issues including the context of the Governments commitment to reaching 2.4% of GDP being spent on R&D by 2027, and the creation of UKRI as an opportunity for planning how this can be achieved.
  • Professor Jakob Edler, Executive Director, Fraunhofer Institute for Systems and Innovation Research, Germany
    Dr Jos van den Broek, Senior Researcher, Rathenau Instituut, Netherlands
    Professor Paul Nightingale, Professor of Strategy, Science Policy Research Unit, University of Sussex, and (designate) Director of Strategy and Operations, ESRC
    Professor Joanna Chataway, Head of Department, Science, Technology, Engineering and Public Policy, University College London, and Deputy Director of Science Policy Research Unit, University of Sussex
    The Committee will also explore international comparisons of R&D spending, the regional distribution of investment, and how R&D can be aligned with social and economic goals.